Guardian Pharmacy Services, Inc. (GRDN) — research page
US · us-cm-kg/NYSE/GRDN · as of 2026-11-08
Identity and listing
The issuer is Guardian Pharmacy Services, Inc., listed on NYSE under ticker GRDN. Its ISIN is US40145W1018 and its LEI is not on the record (no GLEIF record with the exact legal name in jurisdiction US-GA). Its security type is Corporate, its segment is not on the record, its sector is 5912 Retail-Drug Stores and Proprietary Stores, and its jurisdiction is United States, Georgia. The issuer is listed and not halted.
| field | value | source · read date |
|---|---|---|
| name | Guardian Pharmacy Services, Inc. | source · 2026-11-08 |
| exchange | NYSE | source · 2026-11-08 |
| ticker | GRDN | source · 2026-11-08 |
| ISIN | US40145W1018 | source · 2026-09-29 |
| LEI | not on the record | |
| security type | Corporate | source · 2026-11-08 |
| segment | not on the record | |
| sector | 5912 Retail-Drug Stores and Proprietary Stores | source · 2026-11-08 |
| jurisdiction | United States — Georgia | source · 2026-11-08 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 84 filings in the window 2025-11-08 to 2026-11-08, across 27 filing days. Filings by type are 52 directors' dealings, 11 results, 10 regulatory filings, 4 prospectuses, 3 AGM/EGM notices, 3 corporate news, and 1 director change. The median gap between filing days is 8.0 days, against a NYSE median of 6.0 days and a sector median of 6 days. The latest filing is dated 2026-11-05 and is of type results, 3 days before the record date. Latency is 3 days, against a NYSE median of 4.0 days and a sector median of 2 days. The NYSE median filing count over the window is 64.0 and the sector median is 44.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 84 | 8 | 3 |
| exchange median: NYSE (3256 issuers) | 64 | 6 | 4 |
| sector median: 5912 Retail-Drug Stores and Proprietary Stores (5 issuers) | 44 | 6 | 2 |
| date | type | category | filing |
|---|---|---|---|
| 2026-11-05 | results | 10-Q | 10-Q — 10-Q |
| 2026-11-05 | results | 8-K | 8-K — 8-K (items 2.02,9.01) |
| 2026-11-05 | regulatory_filing | SCHEDULE 13G/A | SCHEDULE 13G/A |
| 2026-09-28 | directors_dealings | 4 | 4 — 4 |
| 2026-09-28 | directors_dealings | 4 | 4 — 4 |
window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is Ernst & Young LLP, located in Atlanta, Georgia. The record holds no auditor changes.
Events and halts
The record holds no listing, delisting or name change lines. The domicile change is not on the record (EDGAR states no dated change of state of incorporation on a filing line). The segment move is not on the record (the exchanges' tier transfers are not EDGAR filings). The halt flag is listed, not halted.
Orderability
The outcome is not determinable because the chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.
rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
The issuer's own investor-relations page names 5 research houses: Jefferies, Oppenheimer, Raymond James, Stephens and Truist.
| research house | analyst | source · read date |
|---|---|---|
| Jefferies | Brian Tanquilut | issuer page · 2026-11-11 |
| Oppenheimer | Michael Wiederhorn | issuer page · 2026-11-11 |
| Raymond James | John Ransom | issuer page · 2026-11-11 |
| Stephens | Raj Kumar | issuer page · 2026-11-11 |
| Truist | Dave MacDonald | issuer page · 2026-11-11 |
Open research
No openly published research notes were found on the record.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The vintage is sealed. Sealed years that hold the issuer are 2021, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12.
Sources
9 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- 10.2
- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
- 10.3
- https://data.sec.gov/submissions/CIK0001802255.json (identity.jurisdiction)
- 10.4
- https://mcp.us-cm-kg.ai/events/NYSE/GRDN (the disclosure lines)
- 10.5
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- 10.6
- https://www.sec.gov/Archives/edgar/data/1802255/000119312526102172/d16111d10k.htm (the auditor)
- 10.7
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.8
- https://investors.guardianpharmacy.com/stock-info/analyst-coverage/default.aspx (coverage)
- 10.9
- https://mcp.us-cm-kg.ai/record/NYSE/GRDN (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getissuer.ai/mcp with {"isin":"US40145W1018"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:df27fa9cbc741a46.